Research indicates that NFATC2 regulates the expression of matrix metalloproteinase 13 (MMP13) in BC cells through interactions with other proteins, thereby promoting the invasiveness of cancer cells (48), which provides a new therapeutic target for BC treatment. Here, NFATC2 is linked to cancer.